Biotechnology Market Research Reports & Industry Analysis
Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.
Biotech Market Research to Fuel Business Growth
Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:
- Current market performance, industry outlooks, and industry lifecycles
- Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
- Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
- Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies
Stay Ahead with our Biotechnology Industry Analysis
The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.
Biotechnology Industry Research & Market Reports
-
Plant Biotechnology Market by Product Type (Crop Protection & Nutrition Solution Products, Biotech Seed & Traits, Synthetic Biology Enabled Products), Technology Type, Crop Type, End User, and Region - Global Forecast to 2030
... period. The plant biotechnology market has emerged as a critical sector within the broader agricultural and life sciences industries, driven by the increasing global demand for sustainable food production, climate-resilient crops, and innovative biopharmaceutical solutions. ... Read More
-
2025 Global Gene Therapy For Mucopolysaccharidosis Market Industry (2031 Outlook)
... data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, ... Read More
-
2025 Global Gene Therapy Products Market Industry (2031 Outlook)
... for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology ... Read More
-
2025 Global Gene Therapy Market Industry (2031 Outlook)
... a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology analysis, ... Read More
-
Desalting & Buffer Exchange
... 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Filtration, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$1.1 Billion by the end ... Read More
-
Drug Discovery Outsourcing
... at a CAGR of 6.5% over the analysis period 2024-2030. Lead Identification & Candidate Optimization, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$3.0 Billion by ... Read More
-
Glucose Biosensors
... CAGR of 2.1% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$1.5 Billion by the end of the analysis period. ... Read More
-
Live Cell Encapsulation
... at a CAGR of 3.8% over the analysis period 2024-2030. Alginate, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$117.8 Million by the end of the ... Read More
-
Molecular Biology Enzymes and Kits & Reagents
... expected to reach US$70.5 Billion by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 14.6% ... Read More
-
Next Generation Cancer Diagnostics
... 2030, growing at a CAGR of 21.8% over the analysis period 2024-2030. qPCR & Multiplexing, one of the segments analyzed in the report, is expected to record a 22.8% CAGR and reach US$28.2 Billion by ... Read More
-
Nutrigenomics
... 16.2% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$2.0 Billion by the end of the analysis period. ... Read More
-
Plant Cell Culture Equipment
... 2030, growing at a CAGR of 13.7% over the analysis period 2024-2030. Centrifuges, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$784.8 Million by the end ... Read More
-
Immunochemicals
... 5.1% over the analysis period 2024-2030. Catalog Antibodies, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth ... Read More
-
Epigenetics
... 18.2% over the analysis period 2024-2030. Epigenetics Kits, one of the segments analyzed in the report, is expected to record a 19.2% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth ... Read More
-
Synthetic Biology
... CAGR of 27.9% over the analysis period 2024-2030. Oligonucleotides & Synthetic DNA, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$39.5 Billion by the end of ... Read More
-
High Throughput Screening (HTS)
... 2030, growing at a CAGR of 0.9% over the analysis period 2024-2030. Consumables / Reagents, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$16.9 Billion by ... Read More
-
Next Generation Sequencers
... at a CAGR of 17.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$26.6 Billion by the end of the ... Read More
-
Biobanks
... 7.7% over the analysis period 2024-2030. Physical / Real, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$108.4 Billion by the end of the analysis period. ... Read More
-
Biomarkers
... 13.7% over the analysis period 2024-2030. Safety, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$89.8 Billion by the end of the analysis period. Growth in ... Read More
-
Mesenchymal Stem Cells (MSC)
... 2030, growing at a CAGR of 12.2% over the analysis period 2024-2030. Bone Marrow, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$3.4 Billion by the ... Read More
-
Predictive Diagnostics
... CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$821.4 Million While China is Forecast to Grow at 9.9% CAGR The Predictive Diagnostics market in the U.S. is estimated at ... Read More
-
Personalized Medicines
... CAGR of 4.6% over the analysis period 2024-2030. Personalized Nutrition & Wellness, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$484.0 Billion by the end of ... Read More
-
Antimicrobial Susceptibility Testing
... at a CAGR of 3.4% over the analysis period 2024-2030. Manual Products, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Microplate Systems
... CAGR of 4.6% over the analysis period 2024-2030. Readers, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$851.2 Million by the end of the analysis period. ... Read More
-
Small Molecule Drug Discovery
... 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Oncology Therapeutic Area, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$38.9 Billion by ... Read More
Research Assistance
